Patents Assigned to Boston Life Sciences
  • Publication number: 20060211614
    Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homologous to amino acid residues 130-137 or 132-139 of human troponin subunit I.
    Type: Application
    Filed: January 5, 2006
    Publication date: September 21, 2006
    Applicants: Boston Life Sciences, Children's Medical Center Corporation
    Inventors: Richard Thorn, Marc Lanser, Marsha Moses, Dmitri Wiederschain